BioUtah News
-
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting
-
PhotoPharmics Phase 2 Parkinson’s Disease
PhotoPharmics will be attending the American Academy of Neurology Annual Meeting (AAN) in Chicago, April 18-22.
-
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
-
Freyya Selected as Finalist for Tech Fuel 2026
Freyya Selected as Finalist for Tech Fuel 2026
-
The “White Glove” Delivery: How a Joke Landed Me in Iceland
The “White Glove” Delivery: How a Joke Landed Me in Iceland
-
Owlet Dream Duo™ 3 Named ‘Best for Monitoring Baby’s Health’ in PARENTS 2026 Best for Baby Awards
The Only Pediatric Health Platform Pairing an FDA-Cleared Infant Wearable with a Cybersecurity-Certified Video Monitor Earns Top Recognition…
-
Kimbell & Associates: Highlights of President Trump’s FY 2027 Budget Request
Kimbell & Associates offers highlights of President Trump’s FY 2027 Budget Request
-
Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share
By Henry O’Connell, Canary Speech Five years into caring for a patient, a primary care physician saw her…
-
University of Utah Earns Dual Recognition in Global and U.S. Patent Rankings
Author: Amanda Ashley, Director of Communications for Research & Innovation, Office of the Vice President for Research The…
-
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader…
-
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
First biodistribution study of the Company’s novel targeted lipid nanoparticle achieved systemic circulation with the potential to target…
-
TWO YEAR DATA ON EDWARDS LIFESCIENCES’ EVOQUE SYSTEM CONTINUE TO DEMONSTRATE SIGNIFICANT AND SUSTAINED PATIENT BENEFITS
TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
